Lansoprazole Capsule, Delayed Release
Product Images NDC 27241-019

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 27241-019). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajanta Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lansoprazole_figure1 (Lansoprazole Figure1)

Lansoprazole_figure1 (Lansoprazole Figure1)
This is a graph showing the mean severity of day heartburn by study day for evaluable patients. The severity is rated on a scale of 0 (none) to 3 (severe), with 1 being mild and 2 being moderate. The graph represents data from a study involving a medication called Lamsoprazte (15mg). The x-axis shows the days from the start of treatment.*
FDA Label Image

Lansoprazole_figure2 (Lansoprazole Figure2)

Lansoprazole_figure2 (Lansoprazole Figure2)
The text describes the mean severity of night heartburn for patients who took either a placebo or different doses of Lansoprazole (a medication used to treat stomach and esophagus problems) measured over 55 days from the start of treatment. The severity of heartburn was classified as none, mild, moderate, or severe on a scale of 0 to 3. The chart shows that the severity of night heartburn decreased over time for all treatment groups, with the Lansoprazole 30 mg dose having the most significant reduction in severity.*
FDA Label Image

Lansoprazole 15mg

Lansoprazole 15mg
This is a medication bottle containing 30 Lansoprazole Delayed-Release Capsules USP created by Ajanta Pharma USA Inc. Each blue and pink capsule contains 15 mg of Lansoprazole, USP as enteric-coated granules. This package should not be accepted if the seal over the bottle opening is broken or missing. It should be dispensed in a USP tight container and should be kept away from children. The package is child-resistant and should be stored at 25°C (77°F), excursions from 15°C to 30°C (59°F to 86°F). Please see the enclosure for full prescribing information.*
FDA Label Image

Lansoprazole 30mg

Lansoprazole 30mg
This is a medication bottle containing green and pink capsules of Lansoprazole, used to treat various stomach and intestinal conditions. The capsules are child-resistant and have an enteric-coated granule formula. The label warns the user not to accept if the seal is broken or missing, store the medication at an appropriate temperature range of 15°C to 30°C, and to keep it out of the reach of children. The provided enclosure contains detailed prescribing information. The package is distributed by Ajanta Pharma USA Inc. and is made in India.*
FDA Label Image

Structure (Lansoprazole Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.